Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Nial Wheate, Professor, School of Natural Sciences, Macquarie University

Here’s what’s different about Slinda, the single-hormone contraceptive just added to the PBS

areeya_ann/Shutterstock

From May 1, the oral contraceptive Slinda (drospirenone) will be listed on the Pharmaceutical Benefits Scheme (PBS). This means the price will drop for the more than 100,000 Australian women who currently use it – from around $A320 a year to around $94.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.